Search research articles
Contact Us
Filters
Showing results (21-30 of 39) with videos related to
Page
of 4
Sort By:
The Milbank Quarterly
|
August 10, 2021
Who Would Pay Higher Taxes for Better Mental Health? Results of a Large-Sample National Choice Experiment
F Reed Johnson, Juan Marcos Gonzalez, Jui-Chen Yang, et al.
The American Journal of Managed Care
|
September 10, 2011
Cost-offset analysis: bimatoprost versus other prostaglandin analogues in open-angle glaucoma
Karina L Berenson, Steven Kymes, David A Hollander, et al.
Health Science Reports
|
February 1, 2021
Characterization of the changes in supine blood pressure with long-term use of droxidopa in patients with neurogenic orthostatic hypotension
L Arthur Hewitt, Annika Lindsten, Stephen Gorny, et al.
Health Affairs (Project Hope)
|
March 6, 2013
A hospital system's wellness program linked to health plan enrollment cut hospitalizations but not overall costs
Gautam Gowrisankaran, Karen Norberg, Steven Kymes, et al.
Journal of Comparative Effectiveness Research
|
May 24, 2023
Comparison of indirect treatment methods in migraine prevention to address differences in mode of administration
Christopher G Fawsitt, Howard Thom, Stephane A Regnier, et al.
The American Journal of Managed Care
|
May 31, 2017
Economic value of pharmacist-led medication reconciliation for reducing medication errors after hospital discharge
Mehdi Najafzadeh, Jeffrey L Schnipper, William H Shrank, et al.
The Journal of Allergy and Clinical Immunology
|
October 2, 2012
Modeling asthma exacerbations through lung function in children
Ann Chen Wu, Martin Gregory, Steven Kymes, et al.
Neurology and Therapy
|
February 2, 2022
Durability of the Clinical Benefit of Droxidopa for Neurogenic Orthostatic Hypotension During 12 Weeks of Open-Label Treatment
Robert A Hauser, Antonella Favit, L Arthur Hewitt, et al.
The Journal of Headache and Pain
|
March 29, 2024
Structural equation modeling for identifying the drivers of health-related quality of life improvement experienced by patients with migraine receiving eptinezumab
Linus Jönsson, Susanne F Awad, Stephane A Regnier, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
May 31, 2023
Estimating treatment effects on health utility scores for patients living with migraine: a post hoc analysis of the DELIVER trial
Linus Jönsson, Stephane A Regnier, Steven Kymes, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 39) with videos related to
Sort By:
Page
of 4
The Milbank Quarterly
|
August 10, 2021
Who Would Pay Higher Taxes for Better Mental Health? Results of a Large-Sample National Choice Experiment
F Reed Johnson, Juan Marcos Gonzalez, Jui-Chen Yang, et al.
The American Journal of Managed Care
|
September 10, 2011
Cost-offset analysis: bimatoprost versus other prostaglandin analogues in open-angle glaucoma
Karina L Berenson, Steven Kymes, David A Hollander, et al.
Health Science Reports
|
February 1, 2021
Characterization of the changes in supine blood pressure with long-term use of droxidopa in patients with neurogenic orthostatic hypotension
L Arthur Hewitt, Annika Lindsten, Stephen Gorny, et al.
Health Affairs (Project Hope)
|
March 6, 2013
A hospital system's wellness program linked to health plan enrollment cut hospitalizations but not overall costs
Gautam Gowrisankaran, Karen Norberg, Steven Kymes, et al.
Journal of Comparative Effectiveness Research
|
May 24, 2023
Comparison of indirect treatment methods in migraine prevention to address differences in mode of administration
Christopher G Fawsitt, Howard Thom, Stephane A Regnier, et al.
The American Journal of Managed Care
|
May 31, 2017
Economic value of pharmacist-led medication reconciliation for reducing medication errors after hospital discharge
Mehdi Najafzadeh, Jeffrey L Schnipper, William H Shrank, et al.
The Journal of Allergy and Clinical Immunology
|
October 2, 2012
Modeling asthma exacerbations through lung function in children
Ann Chen Wu, Martin Gregory, Steven Kymes, et al.
Neurology and Therapy
|
February 2, 2022
Durability of the Clinical Benefit of Droxidopa for Neurogenic Orthostatic Hypotension During 12 Weeks of Open-Label Treatment
Robert A Hauser, Antonella Favit, L Arthur Hewitt, et al.
The Journal of Headache and Pain
|
March 29, 2024
Structural equation modeling for identifying the drivers of health-related quality of life improvement experienced by patients with migraine receiving eptinezumab
Linus Jönsson, Susanne F Awad, Stephane A Regnier, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
May 31, 2023
Estimating treatment effects on health utility scores for patients living with migraine: a post hoc analysis of the DELIVER trial
Linus Jönsson, Stephane A Regnier, Steven Kymes, et al.
Page
of 4